|
|
FDA Safety Changes: Viramune, Agrylin, Keflex, Furadantin, Mycobutin
|
| Link ID |
8598 |
| Title |
FDA Safety Changes: Viramune, Agrylin, Keflex, Furadantin, Mycobutin |
| Url |
http://www.medscape.com/viewarticle/580357?src=rss |
| Description |
The FDA has approved revisions to the safety labeling for nevirapine tablets and oral solution, anagrelide HCl capsules, cephalexin capsules, nitrofurantoin oral suspension, and rifabutin capsules. Medscape Medical News |
| Category |
Articles > Dermatology |
| Keywords |
|
| Date |
Sep 12, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Dermatology |
| 3. |
HPV Common in Sexually Active Male College Students
|
|
|
In a study of heterosexually active young male college students, almost two-thirds developed genital human papillomavirus (HPV) infection over 2 years of follow-up, according to Seattle-based researchers. Reuters Health Information
|
| 4. |
FDA Approvals: Voltaren, Menactra, Erbitux
|
|
|
The FDA has approved diclofenac sodium 1% gel, an expanded indication for meningococcal polysaccharide diphtheria toxoid conjugate vaccine, and a new indication for cetuximab injection. Medscape Medical News
|
|
|
